Citation Impact
Citing Papers
Advances in the diagnosis and treatment of Clostridium difficile infections
2018
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
2008
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Antibiotics: past, present and future
2019 Standout
Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development
2016
Leukotriene-receptor antagonists
1999
The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem
2013
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
St. John’s Wort – an Overview
2009 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Novel approaches to treatingClostridium difficile-associated colitis
2015
The Influence of St. John's Wort on the Pharmacokinetics and Protein Binding of Imatinib Mesylate
2004
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry
2009
Where are we with monoclonal antibodies for multidrug-resistant infections?
2019
Natural products: An evolving role in future drug discovery
2011 Standout
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
2012
Oral Anticoagulant Therapy
2012 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Future Coastal Population Growth and Exposure to Sea-Level Rise and Coastal Flooding - A Global Assessment
2015 Standout
Comparison of Once Daily Mometasone Furoate (Nasonex) and Fluticasone Propionate Aqueous Nasal Sprays for the Treatment of Perennial Rhinitis
1997
Mometasone Furoate
1998
Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
1997
Vascular disorders of the liver # †
2008 Standout
Attitudes to vaccination: A critical review
2014 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Macitentan in pulmonary arterial hypertension: The SERAPHIN trial
2014
Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐ and placebo‐controlled study
1996
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Antibiotics in the clinical pipeline in 2013
2013
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
2013
Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells
2008
Inhaled and nasal corticosteroids: safety aspects*
2000
Effect of St John's wort on imatinib mesylate pharmacokinetics
2004
Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler
2001
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
2002 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
2011
Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis
1997
Ezetimibe
2005
Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities
2014 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Microneedles for drug and vaccine delivery
2012 Standout
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Herb-Drug Interactions
2005 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Pharmacokinetics and Bioavailability of Herbal Medicinal Products
2002
In Vivo CYP3A Activity Is Significantly Lower in Cyclosporine-Treated as Compared With Tacrolimus-Treated Renal Allograft Recipients
2011
Anti-bacterial monoclonal antibodies: Back to the future?
2012
Aliskiren: the first renin inhibitor for clinical treatment
2008
Antileukotrienes in asthma: present situation
2001
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Assessing mitochondrial dysfunction in cells
2011 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Characterization of a transcriptional TPP riboswitch in the human pathogen Neisseria meningitidis
2020 StandoutNobel
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Rifampin Combination Therapy for Nonmycobacterial Infections
2010
Absence of Growth Retardation in Children With Perennial Allergic Rhinitis After One Year of Treatment With Mometasone Furoate Aqueous Nasal Spray
2000
Copper Active Sites in Biology
2014 Standout
Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
2015
Cardiovascular effects of Danshen
2007 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Deep genome annotation of the opportunistic human pathogen Streptococcus pneumoniae D39
2018
Interventions for enhancing medication adherence
2008 Standout
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal Glucocorticoid for Allergic Rhinitis
1997
Effect of Posaconazole on Cyclosporine Blood Levels and Dose Adjustment in Allogeneic Blood and Marrow Transplant Recipients
2012
Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Interventions for enhancing medication adherence
2014 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Prosthetic Joint Infection
2014 Standout
Direct Renin Inhibitors as a New Therapy for Hypertension
2010
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
1997
Vaccines: the Fourth Century
2009
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
5‐Substituted 1H‐Tetrazoles as Carboxylic Acid Isosteres: Medicinal Chemistry and Synthetic Methods
2003 Standout
Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers
2002
Works of Michael Seiberling being referenced
Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers*
2004
The effect of anastrozole on the single‐dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers
2001
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults
2008
Effects of oral posaconazole on the pharmacokinetics of sirolimus
2009
Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules
2004
Sotrastaurin and cyclosporine drug interaction study in healthy subjects
2010
Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers
2009
Sotrastaurin and Tacrolimus Coadministration: Effects on Pharmacokinetics and Biomarker Responses
2010
Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects
2004
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers
1997
Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects
2004
METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS
2005
Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
2012
Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult Volunteers
2009
Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers
2007
Absolute Bioavailability of Imatinib (Glivec®) Orally versus Intravenous Infusion
2004
Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults
2012
62 Lack of systemic activity with intranasal mometasone furoate
1996
Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects
2012
[The relative bioavailability and pharmacokinetics of standardized myrtol].
1995
Pharmacokinetics and Safety Profile of the Human Anti- Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers
2009
Elevation of Liver Enzymes in Multiple Dose Trials During Placebo Treatment: Are They Predictable?
1997
Human Pharmacokinetics and Safety Profile of Finafloxacin, a New Fluoroquinolone Antibiotic, in Healthy Volunteers
2011